Clinical Trial Update: A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety and tolerability study of lacosamide as monotherapy in adults with partial-onset seizures has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Epilepsy, Partial-onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2019-06-28